IP
Innate Pharma
IPH.PA·EPAMarseille FRFounded 1999200 employees
Micro CapbiotechPublicOncology
Platform: Lacutamab KIR3
Market Cap
$0.15B
All Drugs
2
Clinical Trials
2
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (IPH.PA)
Loading IPH.PA stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| IPH-2316 | IPH-2316 | Preclinical | 1 | VEGF | Alzheimer'sMS | ||
| Fixasacituzumab | IPH-9873 | NDA/BLA | 1 | CD123 | PsoriasisUC |
SEC Filings & Financial Documents
SEC filings are not available for EPA-listed companies.
Innate Pharma trades on EPA (FR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (1)